{"id":"NCT03782376","sponsor":"Janssen-Cilag Ltd.","briefTitle":"A Study to Evaluate Efficacy and Safety of Ustekinumab Re-induction Therapy in Participants With Moderately to Severely Active Crohn's Disease","officialTitle":"A Phase 3b, Randomized, Double-blind, Multicenter Study to Evaluate the Safety and Efficacy of Intravenous Re-induction Therapy With Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-12-20","primaryCompletion":"2022-08-19","completion":"2023-01-10","firstPosted":"2018-12-20","resultsPosted":"2023-09-13","lastUpdate":"2025-04-29"},"enrollment":215,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Crohn Disease"],"interventions":[{"type":"DRUG","name":"Ustekinumab approximately 6 mg/kg (IV)","otherNames":["STELARA"]},{"type":"DRUG","name":"Placebo (SC)","otherNames":[]},{"type":"DRUG","name":"Placebo (IV)","otherNames":[]},{"type":"DRUG","name":"Ustekinumab 90 mg (SC) Group 1","otherNames":["STELARA"]},{"type":"DRUG","name":"Ustekinumab 90 mg (SC) Group 2","otherNames":["STELARA"]}],"arms":[{"label":"Group 1: Ustekinumab (IV re-induction)","type":"EXPERIMENTAL"},{"label":"Group 2: Ustekinumab (Continuous q8w SC maintenance)","type":"ACTIVE_COMPARATOR"}],"summary":"The primary purpose of this study is to evaluate the efficacy and safety of a single intravenous (IV) re-induction dose of approximately 6 milligram per kilogram (mg/kg) ustekinumab in participants with secondary loss of response (LoR) to subcutaneous (SC) every 8 Weeks (q8w) 90 mg ustekinumab maintenance therapy.","primaryOutcome":{"measure":"Percentage of Participants With Clinical Response at Week 16","timeFrame":"Week 16","effectByArm":[{"arm":"Group 1: Ustekinumab (IV Re-induction)","deltaMin":49.1,"sd":null},{"arm":"Group 2: Ustekinumab (Continuous q8w SC Maintenance)","deltaMin":37.4,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.089"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":6},"locations":{"siteCount":104,"countries":["United States","Austria","Czechia","France","Germany","Italy","Netherlands","Russia","South Korea","Spain","Sweden","United Kingdom"]},"refs":{"pmids":["40357993","34334713"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":9,"n":108},"commonTop":["Crohn's Disease","COVID-19","Headache","Abdominal Pain","Nasopharyngitis"]}}